Trial intelligence / Profile preview

Continuation versus withdrawal of anti-dementia drug therapy in advanced Alzheimer's disease

2017-000042-22Phase 4Active

Sponsor
GAP Mallorca
Start
Mar 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, single-blind trial of donepezil and memantine in Alzheimer's disease (AD) and vascular dementia (2 arms), sponsored by GAP Mallorca. Started Mar 2017; status: active.

02

Drugs

donepezilmemantine
03

Conditions

Alzheimer's disease (AD)vascular dementia

Beyond the preview

Go deeper on 2017-000042-22.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2017-000042-22.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call